Top Markets
Coin of the day
MabCure Inc. MabCure Inc.

MabCure Inc.

MBCI
Rang in Aktien #41405
MabCure Inc., a development stage company, engages in developing and... MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Aktienkurs
$0.0003
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$21.97K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
200.00%
Land
US
Handel MabCure Inc. (MBCI)

Kategorie

Kursverlauf für MabCure Inc. (MBCI)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $1.01 am 2007-12-01
Kursverlauf der Aktie von MabCure Inc. von 2007 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 118.18%
2024 -66.67%
2023 -67.86%
2022 -77.94%
2021 91.39%
2020 243.41%
2019 -68.10%
2018 -32.65%
2017 14.91%
2016 75.25%
2015 -27.57%
2014 -62.58%
2013 -56.22%
2012 -85.27%
2011 -83.42%
2010 -14.01%
2009 -40.28%
2008 -0.99%
2007 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$59.08 62.03%
US
$49.82 72.68%
SE
$183.85 42.90%
FR
$62.57 5.21%
IT
$113.04 55.27%
US